Get started
Author

Tetsuyuki Igarashi

Observed names: T Igarashi, T. Igarashi, Tetsuyuki IGARASHI
Institution: Tenshi Hospital
ORCID: 0000-0003-0099-225X
Observed ORCID: 0000-0003-0099-225X
OpenAlex ID: A5007588535
Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net
2025 · Minoru Kanaya, Masahiro Onozawa, et al. · Blood Cancer Journal · 17
PDF
Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax‐based therapy in the real world: Hokkaido Leukemia Net Study
2024 · Naoki Miyashita, Masahiro Onozawa, et al. · British Journal of Haematology · 14
PDF
Phase II and pharmacokinetic study of rituximab with eight weekly infusions in relapsed aggressive B-cell non-Hodgkin's lymphoma (B-NHL)
2002 · Tetsuyuki Igarashi · 14
Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNP
2014 · Toshiaki Hayashi, Hiroshi Ikeda, et al. · International Journal of Hematology · 12
Decrease of B-type natriuretic peptide to less than 200 pg/mL predicts longer survival in cardiac immunoglobulin light chain amyloidosis
2015 · Kazuya Ishiguro, Toshiaki Hayashi, et al. · International Journal of Hematology · 11
Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia
2022 · Shota Yoshida, Masahiro Onozawa, et al. · International Journal of Hematology · 8
PDF
Evaluation of Venetoclax Duration in Venetoclax-Azacitidine Regimen for Untreated Acute Myeloid Leukemia: Real World Experience from Hokkaido Leukemia Net
2024 · Minoru Kanaya, Masahiro Onozawa, et al. · Blood · 7
PDF
[Primary biliary cholangitis complicated by primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue].
2019 · Tetsuyuki Igarashi, Yoshihiro Yokoyama, et al. · PubMed · 6
Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study
2023 · Naoki Miyashita, Masahiro Onozawa, et al. · Blood · 3
Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia
2022 · Shota Yoshida, Masahiro Onozawa, et al. · Blood · 3
PDF
Reduced FDG Uptake in the Brain on Baseline 18FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Intravascular Large B-Cell Lymphoma and Advanced-Stage Diffuse Large B-Cell Lymphoma
2024 · Hajime Senjo, Shinpei Harada, et al. · Blood · 2
PDF
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group
2024 · Koh Izumiyama, Tasuku Inao, et al. · Haematologica · 2
Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy
2020 · Kazuya Ishiguro, Yasushi Sasaki, et al. · Medicine · 2
Human herpesvirus 6 encephalitis in a patient with glucocorticoid therapy for inflammatory abdominal aortic aneurysm
2014 · Hidetaka YAJIMA, Motohisa YAMAMOTO, et al. · Japanese Journal of Clinical Immunology · 2
PDF
Elevated FDG Uptake in the Lung Is a Characteristic Finding of Intravascular Large B-Cell Lymphoma
2022 · Shinpei Harada, Hideki Goto, et al. · Blood · 1
Incidentally Detected Complex Karyotypic Abnormalities in the Bone Marrow Provide a Clue to Diagnosing Intravascular Large B-Cell Lymphoma
2022 · Shinpei Harada, Hideki Goto, et al. · Blood · 1
Positive Pattern Recognition System Using Alanine Aminotransferase, Type IV Collagen 7s, and E Value (Liver Stiffness) for the Diagnosis of Nonalcoholic Steatohepatitis Based on Natural History
2022 · Masayuki Tsujisaki, Shigeru Sasaki, et al. · JMA Journal · 1
Addition of Bortezomib to Melphalan Plus Dexamethasone Provides Rapid Response in AL Amyloidosis
2014 · Toshiaki Hayashi, Tetsuyuki Igarashi, et al. · Blood · 1
[Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation].
2012 · Tetsuyuki Igarashi, Toshiaki Hayashi, et al. · PubMed · 1
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan
2026 · Fumiaki Fujii, Masahiro Onozawa, et al. · International Journal of Hematology
Multiple myeloma with ≥1% circulating plasma cells in peripheral blood has a poor prognosis
2025 · Kosuke Miki, Koh Izumiyama, et al. · Blood
Thrombotic risk with thrombopoietin receptor agonists in immune thrombocytopenia: Real-world evidence from a multicenter Japanese study.
2025 · Masahiro Yoshida, Satoshi Iyama, et al. · Blood
PDF
Baseline 18f-Fluorodeoxyglucose PET/CT Radiomics Predicts Outcome in Newly Diagnosed Intravascular Large B-Cell Lymphoma
2023 · Shinpei Harada, Hideki Goto, et al. · Blood
Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)
2023 · Kisato Nosaka, Shigeru Kusumoto, et al. · Blood
PDF
Addition of High-Dose Methotrexate to Initial Chemotherapy Improved Treatment Outcome of Patients with Newly Diagnosed Intravascular Large B-Cell Lymphoma: A Multicenter, Retrospective Study
2023 · Shinpei Harada, Hideki Goto, et al. · Blood
PDF
Works count: 30
Citation count: 108
H-index: 7
I10-index: 5
Year
Topic
Type